Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
about
SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancerFrizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoidsThe human homolog of the Drosophila headcase protein slows down cell division of head and neck cancer cellsMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersSystematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancerBy moonlighting in the nucleus, villin regulates epithelial plasticity.Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinomaSustained proliferation in cancer: Mechanisms and novel therapeutic targetsTuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transitionDedifferentiation of foetal CNS stem cells to mesendoderm-like cells through an EMT processDaxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis.Highly proliferative sellar chordoma with unusually rapid recurrence.Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulationSNAI2/Slug promotes growth and invasion in human gliomas.Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancerSLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumourMiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cellsA three-dimensional in vitro model of tumor cell intravasation.Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinomaThe E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.Expression of transcription factors snail, slug, and twist in human bladder carcinomaE-cadherin and the cytoskeletal network in colorectal cancer development and metastasis.Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarrayEMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancerNHERF1/EBP50 is a new marker in colorectal cancer.RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMAThe T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression.Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressivenessDownregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patientsEpithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionSlug contributes to cancer progression by direct regulation of ERα signaling pathwayFOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers.Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.Slug expression during melanoma progressionRelation between proinflammatory mediators and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells.
P2860
Q24298176-AA8FA878-2061-4A93-B632-FB970161D575Q24305464-34AF72FB-6F79-4A50-A194-13BB0C37999EQ24318687-3152A33A-560E-495D-80DA-AE8F62AA3F10Q24674085-44422ABE-A668-4335-941D-BA0541157DC3Q26738551-78868029-FF90-4FB6-822F-74CD648866B7Q27305288-011F6D34-1DB3-4AD9-A153-0A214F2BD2D2Q28291175-FD046B71-7CB3-4EDC-AAD9-AAA7843667ABQ28396388-831F7673-2B0D-4472-83DD-FFB2FD18E0C5Q28566030-5CBBBC39-8AB4-447C-A537-1569335B93ACQ28732522-34BA9BB2-44ED-455B-A065-5BB56EE2EAE5Q30833310-419CBCB8-C634-4F64-845E-E862AF0CD18BQ33274605-C9C6B6D2-2F77-4744-8861-F63B8DA94E9FQ33482559-482C6919-7250-4AF7-9630-CBE4766CAA62Q33611026-59CC995C-4FB8-4429-AFD9-48FD8EDCBDC8Q33636318-AC4DC061-EAF0-4051-A0E8-647C22F97F94Q33639728-547FFE38-621D-4BF8-8EE9-6B354F368C31Q33648460-01110D23-CB95-4EDF-84A5-E1E60A709514Q33716526-FCB64148-D69E-40C8-85E2-179042882D5BQ33879485-043C42E3-92E4-4427-9391-76638FFE24DFQ33902453-3544297E-A327-4DE5-8B7D-4D4017C82D66Q34000543-47F1050A-54B5-456D-A800-D41D612DD641Q34142066-1A6E00FA-2B0E-45A6-93D9-358095FDE368Q34241196-F73360FE-C1E4-4B02-B4D8-A5A5076C1BE3Q34283703-5604F0FC-EBF5-4C8C-A52B-936F03B910E0Q34365738-A688D7B2-0F5F-4F83-A7AE-BA237690A275Q34411711-7B3D2C1F-744F-4B5B-9BB2-E2AD37870DE9Q34578107-68685747-FF9A-407F-9FC7-31F1820E8666Q34665751-F4893C7B-8D56-40CA-A3E2-5DF51C43521CQ34694101-9D63F8DE-06B5-4AD5-A3F3-D0232807875CQ34885299-CF00BF05-BCB5-4492-A067-D0924C2604C0Q34907373-0675B88F-5BBC-4B3B-B78C-F0FB38FB4208Q35075444-A1339808-FC06-4692-AF4E-9241CD1171D6Q35102335-988DD68A-5D97-41DB-A3D5-75294B2B5BB1Q35168129-2F44D224-81BC-47F4-BC2D-086453787A39Q35348316-EDA20878-A413-4CBC-BB41-5444A5DBFC13Q35973861-C6C8F95C-2E0A-49C9-8EAF-E6831A373B92Q36018843-96B583DF-4E87-419A-B002-2A3A94810EB3Q36044631-0FA45F01-CC82-4C4D-B910-D403C47A0B50Q36244152-9E9A09DE-5016-4EEE-B37A-F2F17F66891CQ36430004-DCA4504E-342A-410B-A17D-A08854F6A5B4
P2860
Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Slug expression is an independ ...... colorectal carcinoma patients
@ast
Slug expression is an independ ...... colorectal carcinoma patients
@en
type
label
Slug expression is an independ ...... colorectal carcinoma patients
@ast
Slug expression is an independ ...... colorectal carcinoma patients
@en
prefLabel
Slug expression is an independ ...... colorectal carcinoma patients
@ast
Slug expression is an independ ...... colorectal carcinoma patients
@en
P2093
P2860
P356
P1476
Slug expression is an independ ...... colorectal carcinoma patients
@en
P2093
M Miyazaki
M Nishimura
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603193
P407
P577
2006-06-01T00:00:00Z